Aurobindo Pharma gets USFDA nod for generic of Revatio drug

Aurobindo Pharma gets USFDA nod for generic of Revatio drug

The drug is used to treat pulmonary arterial hypertension and improve exercise capacity in adults

FPJ Web DeskUpdated: Thursday, December 29, 2022, 11:16 AM IST
article-image
Image credit: Wikipedia (Representative)

Aurobindo Pharma Ltd has received USFDA (US Food and Drug Administration) approval to market sildenafil citrate oral suspension in a 10 mg per mL strength, according to an update on the drug regulator's website.

The drug is a generic version of Viatris Inc's Revatio oral suspension.

It is used to treat pulmonary arterial hypertension and improve exercise capacity in adults.

RECENT STORIES

India's Auto Component Industry Grows 6.8% YoY To ₹3.56 Lakh Crore In H1 FY26, Exports Up 9.3%
India's Auto Component Industry Grows 6.8% YoY To ₹3.56 Lakh Crore In H1 FY26, Exports Up 9.3%
Mercedes-Benz India Becomes First Market Outside US To Locally Produce Ultra-Luxury Mercedes-Maybach...
Mercedes-Benz India Becomes First Market Outside US To Locally Produce Ultra-Luxury Mercedes-Maybach...
HDFC AMC Profit Rises To ₹769 Crore In Q3, Revenue Touches ₹1,254 Crore, Outpaces Q1 & Q2...
HDFC AMC Profit Rises To ₹769 Crore In Q3, Revenue Touches ₹1,254 Crore, Outpaces Q1 & Q2...
ED Attaches ₹35 Crore Assets Of Suumaya Group Under PMLA In ₹137 Crore Investor Fraud Case
ED Attaches ₹35 Crore Assets Of Suumaya Group Under PMLA In ₹137 Crore Investor Fraud Case
Germany’s Chancellor Merz Declares India Key Partner In Trade, Defence & Technology During...
Germany’s Chancellor Merz Declares India Key Partner In Trade, Defence & Technology During...